↓ Skip to main content

Dose-intense capecitabine, oxaliplatin and bevacizumab as first line treatment for metastatic, unresectable colorectal cancer: a multi-centre phase II study

Overview of attention for article published in BMC Cancer, October 2014
Altmetric Badge

Citations

dimensions_citation
4 Dimensions

Readers on

mendeley
24 Mendeley